androgenetic alopecia
Conditions
Interventions
Bald area injection side:A total of 40-50u of botulinum toxin was injected intradermally at 20-25 injection sites in the balding area on the injected side of the baldness, and an equal amount of salin
Muscular area injection side:Lateral injections in the muscular area were given intramuscularly at 20-25 injection sites in the temporal and occipital muscular areas for a total of 40-50u of botulinum
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: ?Patients who are 18 years of age or older ? Patients diagnosed with androgenetic alopecia with manifestations of female pattern baldness, and with a BSAP classification greater than M3 ?Patients with no history of treatment with known interfering botulinum toxin medications within the past 6 months. ? Patients who are willing and able to complete re-injection at 3 months and 6 months after the first injection and follow-up at 9 months after the first injection. ? Patients with normal Chinese or English reading and comprehension skills. ? Patients who are not in pregnancy or breastfeeding.
Exclusion criteria
Exclusion criteria: ? Patients presenting with severe visceral, eye or skin diseases were excluded; ? Diseases of the neuromuscular system; ? Inflammation, infection or unhealed wounds of the skin around the head injection site; ? Systemic treatment with glucocorticoids or other immunosuppressive and immunomodulatory agents in the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair count; | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment Effectiveness Score;Patient satisfaction rating; | — |
Countries
China
Contacts
Public ContactShu Zhang
Department of Dermatology, West China Hospital, Sichuan University.
Outcome results
None listed